This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Imagine spending weeks building trust with a doctor or pharmacist, only to find out that counterfeit versions of your product are circulating in the market. It’s a reality for many of us in pharma sales in Malaysia. Why This Hits Close to Home for Pharma Reps As someone in pharma sales, this problem feels personal.
INTERPHEX 2023 is right around the corner, taking place April 25-27 at the Javits Center in NYC. From development to distribution, INTERPHEX is the leading global event that takes you through all stages of the pharmaceuticalproduct development lifecycle. LB Bohle LLC Korber Pharma North America Syntegon Pharma Technology, Inc.
Results from CPhI’s 2022 Pharma Index survey , announced at this year’s CPhI Frankfurt, showed pharma confidence in growth , innovation and manufacturing quality has reached record highs, promising positive prospects for the industry in 2023 and beyond. Key countries. Scores this year were the highest on record ( Figure 2 ).
Lotus Pharmaceuticals and Teraju Pharma have entered a strategic partnership to market Lotus’s products in a range of therapeutic areas in Malaysia. Teraju Pharma will be responsible for marketing and promoting the products using its relationships and infrastructure.
market until next year, with the pharmaceutical company announcing Tuesday a settlement with the Iceland-based Alvotech. billion last year, the highest total for any pharmaceuticalproduct and they will do anything to keep that money. Sales of Humira earned AbbVie $20.7 The executives at AbbVie make over $300 million.
Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. To some extent, the pharmaceutical sector is more resilient to these challenges than other industries.
4 Together with a legal expert from the Bucerius Law School Hamburg, we looked at the legal and political frameworks that could enable the German pharmaceutical sector to become more sustainable. Strengthening sustainability in the pharmaceutical sector. Climate-conscious prescription of inhaled medicinal products. cited 23Apr].
Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. To some extent, the pharmaceutical sector is more resilient to these challenges than other industries.
Prior to joining Clarivate, Levy held several roles in the pharmaceutical industry, including at Veeva Systems, PharmaceuticalProduct Development (PPD) and Accenture. Use of artificial intelligence (AI) and machine learning (ML) in pharma “AI/ML is in most technologies, and in most pharmaceutical companies,” Levy explains.
Alembic Pharmaceuticals Ltd-Walk-In Interviews for API/ Injectable- Production On 7th Jan’ 2023. Alembic Pharmaceuticals Ltd. is an Indian multinational Pharmaceutical company headquartered in Vadodara city of Gujarat-India. Alembic pharmaceuticals Ltd. Date: 7th Jan’ 2023. Executive/ Jr.
He adds that in the early 2000s there were no set standards for RFID in the pharma industry, so the compatibility between systems was not guaranteed. In August of 2022, Fresenius Kabi announced a three-year plan to add GS1 Data Matrix barcodes, also known as 2D barcodes, to its US pharmaceutical portfolio.
Demand for process analytical technology ( PAT ) is being driven by the growing adoption of automation and digitalisation in sectors such as pharmaceutical industry, a report by Market.us With PAT being widely used in pharma, rising R&D expenses are anticipated to boost demand for these technologies.
Second, the production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic (usually transplant) departments. Approved cellular and gene therapy products [Internet]. FDA; 2022 [cited 2023 Mar]. 6-8 Clinical recommendations also change. 2021;3(S1):6–10.
Pfizer, in addition to promising carbon neutrality by the same date via a 46% reduction in direct emissions and 100% renewable electricity purchasing, says its North American operations will be entirely solar powered by the end of 2023. A similar theme is evident in company filings.
5] Regulatory developments and their impact In January of 2023, Denmark, Germany, the Netherlands, Sweden, and Norway proposed an EU-wide ban on a large cache of per- and polyfluoroalkyl substances (PFAS) under Registration, Evaluation, Authorization and Restriction of Chemicals (REACH).
Therapeutic Talk: Doctors’ Reactions to Recent FDA Approvals in Respiratory, Gastro, Infectious Disease, and More The number of times HCPs mentioned new products approved by the FDA over the course of the month of May.
Before you sit down for your Q4 planning session (we’ll cover that in our next blog), have you and your team stopped to consider what you could do to improve product life cycles in 2023? Keep reading to learn more about how PharmaKinnex can help your team extend product life cycles AND increase profitability by 10X!
Recent guidance published by the European Medicines Agency outlines measures that will be taken to increase preparedness for the autumn/winter 2023-2024. Recommendations were also published earlier this year for all stakeholders in the pharma supply chain. What types of medicinal products are in short supply and why?
Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceuticalproducts. market (source: IQVIA MIDAS, May 2023). billion people in 2023). in the top five European Union markets and 7.1%
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content